BridgeBio
Venture capital · Palo Alto, California, United States
Portfolio collected from the firm’s website, last checked Jul 26, 2026.Raises and exits come from each company’s own SEC and company records.
5Deep-tech portfolio4 active
1Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Endeavor BioMedicines
3Co-investorsShare a portfolio company
Portfolio · 5 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Endeavor BioMedicines | Biotech | Active | May 3, 2024 | $221.7M |
| Fortify Therapeutics | Biotech | Active | — | — |
| Leivis Bio | Biotech | Active | — | — |
| Navire Pharma | Biotech | Active | — | — |
| Eidos Therapeutics | Biotech | Acquired | Apr 12, 2018 | $26.0M |
Peer ranks
Portfolio size#81
Portfolio exits#160
Raises, 12 months#88
Co-investors#221
Co-investors
- Astellas Venture ManagementVenture capital1 shared
- RA CapitalVenture capital1 shared
- Versant VenturesVenture capital1 shared
Sectors
- Biotech5
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.